Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis.

Montgomery AB, Kopec J, Shrestha L, Thezenas ML, Burgess-Brown NA, Fischer R, Yue WW, Venables PJ.

Ann Rheum Dis. 2016 Jun;75(6):1255-61. doi: 10.1136/annrheumdis-2015-207656. Epub 2015 Jul 24.

2.

Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.

Quirke AM, Lugli EB, Wegner N, Hamilton BC, Charles P, Chowdhury M, Ytterberg AJ, Zubarev RA, Potempa J, Culshaw S, Guo Y, Fisher BA, Thiele G, Mikuls TR, Venables PJ.

Ann Rheum Dis. 2014 Jan;73(1):263-9. doi: 10.1136/annrheumdis-2012-202726. Epub 2013 Mar 5.

3.

Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.

Konig MF, Paracha AS, Moni M, Bingham CO 3rd, Andrade F.

Ann Rheum Dis. 2015 Nov;74(11):2054-61. doi: 10.1136/annrheumdis-2014-205385. Epub 2014 May 26.

4.

Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.

Wegner N, Wait R, Sroka A, Eick S, Nguyen KA, Lundberg K, Kinloch A, Culshaw S, Potempa J, Venables PJ.

Arthritis Rheum. 2010 Sep;62(9):2662-72. doi: 10.1002/art.27552.

5.

Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.

Shimada A, Kobayashi T, Ito S, Okada M, Murasawa A, Nakazono K, Yoshie H.

J Periodontal Res. 2016 Feb;51(1):103-11. doi: 10.1111/jre.12288. Epub 2015 Jun 11.

PMID:
26094771
6.

Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study.

Fisher BA, Cartwright AJ, Quirke AM, de Pablo P, Romaguera D, Panico S, Mattiello A, Gavrila D, Navarro C, Sacerdote C, Vineis P, Tumino R, Lappin DF, Apatzidou D, Culshaw S, Potempa J, Michaud DS, Riboli E, Venables PJ.

BMC Musculoskelet Disord. 2015 Nov 4;16:331. doi: 10.1186/s12891-015-0792-y. Erratum in: BMC Musculoskelet Disord. 2016;17:62. Apazidou, Danae [corrected to Apatzidou, Danae].

7.

Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.

Abdullah SN, Farmer EA, Spargo L, Logan R, Gully N.

Anaerobe. 2013 Oct;23:102-8. doi: 10.1016/j.anaerobe.2013.07.001. Epub 2013 Jul 13.

PMID:
23856045
8.

Structure and mechanism of a bacterial host-protein citrullinating virulence factor, Porphyromonas gingivalis peptidylarginine deiminase.

Goulas T, Mizgalska D, Garcia-Ferrer I, Kantyka T, Guevara T, Szmigielski B, Sroka A, Millán C, Usón I, Veillard F, Potempa B, Mydel P, Solà M, Potempa J, Gomis-Rüth FX.

Sci Rep. 2015 Jul 1;5:11969. doi: 10.1038/srep11969.

9.

Extracellular Proteome and Citrullinome of the Oral Pathogen Porphyromonas gingivalis.

Stobernack T, Glasner C, Junker S, Gabarrini G, de Smit M, de Jong A, Otto A, Becher D, van Winkelhoff AJ, van Dijl JM.

J Proteome Res. 2016 Dec 2;15(12):4532-4543. Epub 2016 Oct 19.

PMID:
27712078
10.

Citrullination in the periodontium--a possible link between periodontitis and rheumatoid arthritis.

Laugisch O, Wong A, Sroka A, Kantyka T, Koziel J, Neuhaus K, Sculean A, Venables PJ, Potempa J, Möller B, Eick S.

Clin Oral Investig. 2016 May;20(4):675-83. doi: 10.1007/s00784-015-1556-7. Epub 2015 Aug 13.

11.

Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis.

Kobayashi T, Ito S, Kobayashi D, Shimada A, Narita I, Murasawa A, Nakazono K, Yoshie H.

PLoS One. 2016 Apr 25;11(4):e0154182. doi: 10.1371/journal.pone.0154182. eCollection 2016.

12.

The link between periodontal disease and rheumatoid arthritis: an updated review.

Koziel J, Mydel P, Potempa J.

Curr Rheumatol Rep. 2014 Mar;16(3):408. doi: 10.1007/s11926-014-0408-9. Review.

13.

The peptidylarginine deiminase gene is a conserved feature of Porphyromonas gingivalis.

Gabarrini G, de Smit M, Westra J, Brouwer E, Vissink A, Zhou K, Rossen JW, Stobernack T, van Dijl JM, van Winkelhoff AJ.

Sci Rep. 2015 Sep 25;5:13936. doi: 10.1038/srep13936.

14.

Theoretical insights into the protonation states of active site cysteine and citrullination mechanism of Porphyromonas gingivalis peptidylarginine deiminase.

Zhao C, Ling B, Dong L, Liu Y.

Proteins. 2017 Aug;85(8):1518-1528. doi: 10.1002/prot.25313. Epub 2017 May 25.

PMID:
28486790
15.

Peptidylarginine deiminase from Porphyromonas gingivalis contributes to infection of gingival fibroblasts and induction of prostaglandin E2 -signaling pathway.

Gawron K, Bereta G, Nowakowska Z, Lazarz-Bartyzel K, Lazarz M, Szmigielski B, Mizgalska D, Buda A, Koziel J, Oruba Z, Chomyszyn-Gajewska M, Potempa J.

Mol Oral Microbiol. 2014 Dec;29(6):321-32. doi: 10.1111/omi.12081. Epub 2014 Oct 21.

16.

There's no place like OM: Vesicular sorting and secretion of the peptidylarginine deiminase of Porphyromonas gingivalis.

Gabarrini G, Palma Medina LM, Stobernack T, Prins RC, du Teil Espina M, Kuipers J, Chlebowicz MA, Rossen JWA, van Winkelhoff AJ, van Dijl JM.

Virulence. 2018 Jan 1;9(1):456-464. doi: 10.1080/21505594.2017.1421827.

17.

Peptidyl arginine deiminase from Porphyromonas gingivalis abolishes anaphylatoxin C5a activity.

Bielecka E, Scavenius C, Kantyka T, Jusko M, Mizgalska D, Szmigielski B, Potempa B, Enghild JJ, Prossnitz ER, Blom AM, Potempa J.

J Biol Chem. 2014 Nov 21;289(47):32481-7. doi: 10.1074/jbc.C114.617142. Epub 2014 Oct 16.

18.

Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD).

Maresz KJ, Hellvard A, Sroka A, Adamowicz K, Bielecka E, Koziel J, Gawron K, Mizgalska D, Marcinska KA, Benedyk M, Pyrc K, Quirke AM, Jonsson R, Alzabin S, Venables PJ, Nguyen KA, Mydel P, Potempa J.

PLoS Pathog. 2013 Sep;9(9):e1003627. doi: 10.1371/journal.ppat.1003627. Epub 2013 Sep 12.

19.

Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.

Wegner N, Lundberg K, Kinloch A, Fisher B, Malmström V, Feldmann M, Venables PJ.

Immunol Rev. 2010 Jan;233(1):34-54. doi: 10.1111/j.0105-2896.2009.00850.x. Review.

PMID:
20192991
20.

PPAD is not targeted as a citrullinated protein in rheumatoid arthritis, but remains a candidate for inducing autoimmunity.

Konig MF, Bingham CO 3rd, Andrade F.

Ann Rheum Dis. 2015 Jan;74(1):e8. doi: 10.1136/annrheumdis-2014-206681. Epub 2014 Nov 7. No abstract available.

PMID:
25381231

Supplemental Content

Support Center